Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
Current antidepressant treatments are inadequate for many individuals, and when they are effective, they require several weeks of administration before a therapeutic effect can be observed. Improving the treatment of depression is challenging. Recently, the two-pore domain potassium channel TREK-1 h...
Guardado en:
Autores principales: | Jean Mazella, Olivier Pétrault, Guillaume Lucas, Emmanuel Deval, Sophie Béraud-Dufour, Carine Gandin, Malika El-Yacoubi, Catherine Widmann, Alice Guyon, Eric Chevet, Said Taouji, Grégory Conductier, Alain Corinus, Thierry Coppola, Gabriella Gobbi, Jean-Louis Nahon, Catherine Heurteaux, Marc Borsotto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ce8e5d7cde54153ac1956b5d289c1e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients
por: Roulot M, et al.
Publicado: (2018) -
Mapacalcine protects mouse neurons against hypoxia by blocking cell calcium overload.
por: Hamid Moha Ou Maati, et al.
Publicado: (2013) -
Teaching Trek: Reflections on Participation in the Indo-U.S. Teaching Professorship Program
por: Catherine E. Vrentas
Publicado: (2019) -
The Association Between Sortilin and Inflammation in Patients with Coronary Heart Disease
por: Han W, et al.
Publicado: (2020) -
Emerging roles of sortilin in affecting the metabolism of glucose and lipid profiles
por: Xin Su, et al.
Publicado: (2021)